As thousands and die and more find themselves destitute due to shut down economies across the globe, one thing needs to be made clear. This is the fault of the Chinese government.

From the very beginning, China has attempted to cover up the outbreak, feign control, lie about the contagious nature of the virus, punish anyone who tells the truth, and manipulate foreign media entities into carrying its narrative of being global benefactors.

In that knowledge, if China had knowledge about the nature of the Wuhan Coronavirus and did more to protect its reputation than help the world protect itself from the sickness it unleashed, then it committed a crime against humanity.

That’s exactly what Italian politician Matteo Salvini suggested according to ADNKronos, and he’s right on the money:

“If the Chinese government knew, it did not report and did not protect, it committed a crime against humanity.” So the senator and leader of the League, Matteo Salvini, in a passage of the intervention at Palazzo Madama after the information of Prime Minister Conte in the Chamber. “You cannot pass those who have infected the world as saviors!”, Exclaimed the Northern League.

Salvini is correct. As China continues to attempt to present itself as a leader against the Coronavirus, it’s clear that this is just a mask designed to cover up the fact that it was the Chinese government’s incompetence that lead to the situation the world is in now. If that is the case, then we not only need to be realistic about China and speak in honest terms about them, but they also need to be punished for the crime they committed against nearly every nation on the globe.

At this time, Arkansas Senator Tom Cotton is preparing a bill that will bring drug manufacturing back to the United States. At this time, most of our drugs are manufactured in China.

(READ: Tom Cotton Goes On the Offensive Against China for “Unleashing This Plague” With Bill that Breaks Our Pharmaceutical Dependence)

Our bill would require federal entities like the Department of Defense, VA hospitals, Medicare and Medicaid to cut off purchases of drugs with Chinese ingredients no later than 2025. This requirement would phase in over a period of years to give drug companies time to adjust, but would put clear pressure on importers to stop doing business with the CCP. The bill also would require drug companies to label the origins of ingredients in their drugs, so U.S. consumers are better informed of where their medicine comes from and whether it’s likely to be safe.

Finally, our bill encourages the medical industry to manufacture in our country again by offering full and immediate expensing of factories, warehouses and capital goods related to the manufacture of drugs and medical devices on American soil.

This is a good start. Breaking our drug dependence on China will have three huge benefits. For one, it will bring some 800 thousand high-paying jobs back to the United States according to the Coalition for a Prosperous America:

We use six policy variables in the REMI model to perform the simulation. We reduce imports of pharmaceuticals and medicine manufacturing and basic chemical manufacturing, increase US sales in the pharmaceutical sector and chemical sector. We increase the cost of production in the two sectors by 3.34 percent and 2.59 percent, respectively.

The economy generates 804,000 additional jobs in 2020. The addition to GDP was $200 billion in the first year, or just under 1 percent.  The impact on inflation is insignificant, with inflation rates remaining under 2.3 percent for all five years in both the baseline and the reshoring model. Total US imports were around $40 billion a year lower in the reshoring case The trade deficit remains between $600 billion and $700 billion in both cases. Ironically, the reshoring of pharmaceutical production stimulates the US economy, leading to more imports, partially offsetting the direct reduction in imports from the pharmaceutical reshoring. The improvement in employment and GDP in the reshoring case declines after 2020. We attribute this to the model’s conservative estimation of industry investment. In our view, a reshoring of some $70 billion of production would lead to further investment and employment gains in future years.

Doing so would improve our own economy by leaps and bounds. This, in turn, hurts China as sales of manufacturing drugs from one of its largest importers would disappear, leaving our communist enemy with a large hole in their income.

What’s more, it would break out independence on China for our drugs, which China has threatened recently to cut off and let us “sink into the hell of a novel coronavirus epidemic” if we didn’t go along with the glowing narrative it had created for itself over this pandemic it created.

This is a great start, but it shouldn’t be the end. Manufacturing opportunities should be stripped from China in every industry we can do that with. What’s more, other countries should be willing to part with China as well.

If China is costing lives and ruining economies because of its unwillingness to be realistic about its shortcomings then we should be realistic about what kind of future we may have if we continue to put ourselves at their mercy. It’s time the world turned its back on China.